Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Lehman who wrote (858)	3/27/1998 3:48:00 PM
From: David Culver	Read Replies (1) \| Respond to of 1501

Thanks for the update it has seemed quiet from IZP recently. They used to put out regular news. Dave

To: Harold Lehman who wrote (858)	3/27/1998 8:14:00 PM
From: Robert C. Petersen	Respond to of 1501

Harold, Thank you for your informative post. In the happy event that Inflazyme could attract a top-notch executive, willing to work for short pay, would mean two things as far as I am concerned. 1. The executive could see the "Big Picture" for the company and would be willing to accept options or stock-related compensation. This would renew share holder and future investor confidence in the company. 2. Dr.Salari could devote more of his talent to research. It is difficult to wear two hats in such a competitive field as biotech. Someone expert in dealing with FDA type regulations would lift a lot of weight from the good doctor's shoulders, as this is a time consuming and trying process. It will be interesting to see how this plays out. And, as always, will be appreciative of your take on any news in this area. Thanks again.....nysebob2